Accessibility Menu
Positron logo

Positron(OTC) POSC

Market Cap$55.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1993)-100%
5 Year+80%
1 Year-3%
1 Month-15%
$1.57
-6.55%
-0.11Today
Positron last closing stock price
MetricPriceDate
Last closeUSD 1.572026-07-27
Positron stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-8.19%USD 1.712026-07-20
1 month-15.14%USD 1.852026-06-26
3 month-15.14%USD 1.852026-04-28
Year to date-5.99%USD 1.672025-12-31
1 year-3.09%USD 1.622025-07-25
3 year+4.6%USD 1.502023-07-28
5 year+80.25%USD 0.872021-07-28
Since inception-99.93%USD 2,500.001993-12-03

Positron Financials at a Glance

Market Cap

$55.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$523.12K

Net Income (TTM)

-$10.44M

EPS (TTM)

-$0.32

P/E Ratio

-5.20

Dividend

$0.00

Beta (Volatility)

0.10 (Low)

Price

$1.57

Volume

7,757

Open

$1.65

Previous Close

$1.57

Daily Range

$1.45 - $1.65

52-Week Range

$1.27 - $2.74

Estimated Earnings Date

Nov 23, 2015

POSC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Positron

Positron helps hospitals diagnose heart disease using advanced imaging systems. Its scanners and support services assist doctors in making accurate decisions. The company’s technology aims to improve patient care and streamline medical workflows.

Gadgets and Guarantees: What Positron Sells

  • PET Imaging Systems: Cardiac-focused scanners for hospitals and clinics; 0% of 2025 revenue from equipment sales.
  • PET-CT Imaging Systems: Newer scanners for heart, cancer, and brain imaging; no 2025 revenue yet, pending regulatory clearance.
  • Maintenance Contracts: Service agreements for scanner upkeep; 100% of 2025 revenue.
  • Technical Support: Training, remote diagnostics, and 24/7 assistance for healthcare providers.
  • Flexible Financing: Rental and lease-to-own options to lower upfront costs for medical facilities.

Plot Twists and Partnerships: Growth Moves

  • 2023: Expanded exclusive North American distribution deal with Neusoft Medical Systems for PET and PET-CT systems.
  • 2024-2025: Developed Affinity PET-CT system, targeting oncology and neurology imaging markets.
  • 2025: Provided workflow integration and operational support services for hospitals and clinics.
  • 2025: Raised $10 million through common stock issuance to fund operations and product launches.

Why Positron Is a Bit Different

Positron specializes in heart-focused imaging, offering lower-cost solutions for mid-sized hospitals. Its exclusive partnership with Neusoft gives it unique access to advanced scanner technology. The company’s integrated support model aims to reduce operational barriers for healthcare providers.

Five Things You Need to Know

  • 2025 revenue was $461,452, down 21.5% from 2024.
  • All 2025 revenue came from maintenance contracts; no equipment sales recognized.
  • Net loss grew to $10.6 million in 2025, up 345.6% from 2024.
  • Cash position was $2.5 million at year-end 2025, up from $69,791 in 2024.
  • Management disclosed substantial doubt about continuing as a going concern due to recurring losses.

Bottom Line

Positron has shifted from equipment sales to service contracts while developing new imaging products. The company faces financial challenges but continues to focus on specialized cardiac imaging solutions.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

10

Website

www.positron.com

Headquarters

North Tonawanda, NY 14305, US

POSC Financials

Key Financial Metrics (TTM)

Gross Margin

-442.23%

Operating Margin

-1980.45%

Net Income Margin

-1996.28%

Return on Equity

-767.26%

Return on Capital

-309.59%

Return on Assets

-374.02%

Earnings Yield

-19.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$55.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

32.85M

Volume

7.76K

Avg. Volume

24.24K

Financials (TTM)

Gross Profit

-$2.31M

Operating Income

-$10.36M

EBITDA

-$10.30M

Operating Cash Flow

-$4.60M

Capital Expenditure

-$99.03K

Free Cash Flow

-$4.70M

Cash & ST Invst.

$1.41M

Total Debt

$1.62M

Positron Performance Analysis

Positron annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 727,583-17.5%
20232023-12-31USD 734,6661.0%
20242024-12-31USD 587,500-20.0%
20252025-12-31USD 461,452-21.5%
Positron sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3059.3%
Q32025-09-30-41.6%
Q42025-12-31N/A
Q12026-03-31N/A
Positron annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.12277.7%
20232023-12-31USD -0.07-44.2%
20242024-12-31USD -0.0934.5%
20252025-12-31USD -0.34274.7%
Positron sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3024.3%
Q32025-09-3010.0%
Q42025-12-31-528.7%
Q12026-03-3180.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$111.00K

-7.0%

Gross Profit

-$526.82K

-104.4%

Gross Margin

-4.75%

N/A

Market Cap

$55.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$5.52M

N/A

Employees

10

N/A

Net Income

-$1.38M

+3.4%

EBITDA

-$1.35M

+2.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$1.41M

-63.8%

Total Debt

$1.62M

+4.2%

Accounts Receivable

$0.00

-100.0%

Inventory

$680.00K

-45.9%

Long Term Debt

$146.45K

+546.5%

Short Term Debt

$1.47M

-3.9%

Return on Assets

-3.74%

N/A

Return on Invested Capital

-33.75%

N/A

Free Cash Flow

-$788.71K

-24.6%

Operating Cash Flow

-$788.71K

-24.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VASOVaso Corporation
$0.20+4.06%
GBLPGlobal Pharmatech, Inc.
$0.08+0.00%
GTHPGuided Therapeutics, Inc.
$0.27+1.92%
EMITFElbit Imaging Ltd.
$1.60+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.67-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
NOKNokia
$9.28+0.02%
AALAmerican Airlines Group
$14.95+0.03%

Questions About POSC

What is the current price of Positron?

Positron is trading at $1.57 per share.

What is the 52-week range for Positron?

Over the past 52 weeks, Positron has traded between $1.27 and $2.74.

How much debt does Positron have?

As of the most recent reporting period, Positron reported total debt of $1.62M.

How much cash does Positron have on hand?

Positron reported $1.41M in cash and cash equivalents in its most recent financial results.

What is Positron’s dividend yield?

Positron does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services